Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

BACKGROUND: Men with nonmetastatic, castration-resistant prostate cancer and a rapidly rising prostate-specific antigen (PSA) level are at high risk for metastasis. We hypothesized that enzalutamide, which prolongs overall survival among patients with metastatic, castration-resistant prostate cancer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Hussain, Maha, Fizazi, Karim, Saad, Fred, Rathenborg, Per, Shore, Neal, Ferreira, Ubirajara, Ivashchenko, Petro, Demirhan, Eren, Modelska, Katharina, Phung, De, Krivoshik, Andrew, Sternberg, Cora N.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8288034/
https://ncbi.nlm.nih.gov/pubmed/29949494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1800536
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars